BDX Q4 2024 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q4 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5.4B+6.9% YoY

Gross Profit

$2.5B45.7% margin

Operating Income

$622M11.4% margin

Net Income

$400M7.4% margin

EPS (Diluted)

$1.45

QoQ Revenue Growth

+9.0%

Cash Flow

Operating Cash Flow

$1.2B

Free Cash Flow

$882M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$57.3B

Total Liabilities

$31.4B

Stockholders' Equity

$25.9B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.4B	$5.1B	+6.9%
Gross Profit	$2.5B	$1.7B	+46.2%
Operating Income	$622M	$349M	+78.2%
Net Income	$400M	$108M	+270.4%

Revenue Segments

Medical

$2.8B52%

Life Sciences

$1.3B25%

Interventional

$1.3B23%

Geographic Segments

UNITED STATES

$3.1B57%

Non-US

$2.3B43%